Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 9

1.

Serum steroid and sex hormone-binding globulin concentrations and the risk of incident benign prostatic hyperplasia: results from the prostate cancer prevention trial.

Kristal AR, Schenk JM, Song Y, Arnold KB, Neuhouser ML, Goodman PJ, Lin DW, Stanczyk FZ, Thompson IM.

Am J Epidemiol. 2008 Dec 15;168(12):1416-24. doi: 10.1093/aje/kwn272. Epub 2008 Oct 21.

2.

Monotherapy versus combination drug therapy for the treatment of benign prostatic hyperplasia.

Logan YT, Belgeri MT.

Am J Geriatr Pharmacother. 2005 Jun;3(2):103-14. Review.

PMID:
16129387
3.

Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia.

Bartsch G, Rittmaster RS, Klocker H.

World J Urol. 2002 Apr;19(6):413-25. Review.

PMID:
12022710
4.

The effect of finasteride on prostate specific antigen: review of available data.

Guess HA, Gormley GJ, Stoner E, Oesterling JE.

J Urol. 1996 Jan;155(1):3-9. Review.

PMID:
7490873
5.

Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia.

Bartsch G, Rittmaster RS, Klocker H.

Eur Urol. 2000 Apr;37(4):367-80. Review.

PMID:
10765065
6.

Is screening for prostate cancer necessary in men with symptoms of benign prostatic hyperplasia?

Hall MC, Roehrborn CG, McConnell JD.

Semin Urol Oncol. 1996 Aug;14(3):122-33. Review.

PMID:
8865473
7.

5alpha-reductase inhibitors: what role should they play?

Kaplan SA.

Urology. 2001 Dec;58(6 Suppl 1):65-70; discussion 70. Review.

PMID:
11750255
8.

5alpha-reductase inhibitors in benign prostatic hyperplasia and prostate cancer risk reduction.

Rittmaster RS.

Best Pract Res Clin Endocrinol Metab. 2008 Apr;22(2):389-402. doi: 10.1016/j.beem.2008.01.016. Review.

PMID:
18471794
9.

The link between benign prostatic hyperplasia and prostate cancer.

├śrsted DD, Bojesen SE.

Nat Rev Urol. 2013 Jan;10(1):49-54. doi: 10.1038/nrurol.2012.192. Epub 2012 Nov 20. Review.

PMID:
23165396
Items per page

Supplemental Content

Write to the Help Desk